Clinical Trial Update: Effect of Rosuvastatin and Eicosapentaenoic Acid on Neoatherosclerosis: The LINK-IT Trial [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of Rosuvastatin with Eicosapentaenoic Acid on neoatherosclerosis in coronary artery disease progression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Eicosapentaenoic acid (eicosapentaenoic acid)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Kobe University | Conditions: Coronary Artery Disease Progression | Phase 4 | Status: COMPLETED